International Journal of Clinical Research

Objective To explore the clinical efficacy of blue light combined with supportive therapy in the treatment of pathological jaundice in full-term newborns. Methods From January 2023 to February 2024, 100 full-term newborns with pathological jaundice treated in our hospital during this period were selected as the research subjects. They were randomly divided into two groups according to the order of enrollment: the control group (50 cases) received blue light irradiation treatment, and the observation group (50 cases) received blue light combined with supportive treatment. Results The serum bilirubin index and inflammatory factor levels in the observation group were significantly better than those in the control group. The recovery time of serum bilirubin was shorter, the hospitalization time was shorter, and the overall clinical treatment effective rate was higher, P＜0.05, Has statistical significance. Conclusion The clinical efficacy of blue light combined with supportive therapy for neonatal pathological jaundice is significant, effectively improving relevant physiological indicators of the child and promoting faster recovery. It is recommended to promote its application.

Blue light; Supportive therapy; Neonate; Pathological jaundice; Clinical efficacy